知镜 Cognispect · 医学文献与研究工作台

Present status of prostate cancer diagnosis, limitations, challenges, and future endeavors

Hooda K, Chatterjee M, Sharma AP, et al.
Ann Med · 2026-08-03 · PMID 42544420

文献摘要

Methods: In addition to traditional testing methods, the use of PSMA-directed imaging to guide biopsy procedures using Multiparametric Magnetic Resonance Imaging (mpMRI) allows for better localization and characterization of lesions. Researchers have begun to develop and continue to innovate Molecular & Imaging processes, called Liquid Biopsies, that are now being used to assess health risk factors associated with PC, by sampling macro-molecules from various biological liquids. Recently, the use of Artificial Intelligence (AI) and Machine Learning Models for improving the speed and accuracy of lesion detection and gland segmentation has significantly increased both precision and consistency in these areas. Results: However, there is still great concern regarding overdiagnosis and lack of standardization associated with all types of molecular and imaging techniques currently available. Conclusion: This review provides a comprehensive overview of the currently available diagnostic modalities for prostate cancer, including their weaknesses as well as gaps in clinical translation and standardization, which can assist with providing guidance for future development of diagnostic innovations..

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。